Literature DB >> 17245840

[In focus: Inflammatory cardiomyopathy].

H P Schultheiss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17245840

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  24 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy: light microscopic, immunohistochemical, and virological analyses of myocardium specimens obtained by partial left ventriculectomy.

Authors:  F Terasaki; M Okabe; T Hayashi; S Fujioka; M Suwa; Y Hirota; Y Kitaura; K Kawamura; T Isomura; H Suma
Journal:  J Card Surg       Date:  1999 Mar-Apr       Impact factor: 1.620

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Immunosuppressive therapy for myocarditis.

Authors:  B Maisch; F Camerini; H P Schultheiss
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

5.  Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.

Authors:  A Staudt; F Schäper; V Stangl; A Plagemann; M Böhm; K Merkel; G Wallukat; K D Wernecke; K Stangl; G Baumann; S B Felix
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

6.  Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.

Authors:  Fabian Knebel; Marco Böhm; Alexander Staudt; Adrian C Borges; Mirko Tepper; Nicoline Jochmann; Klaus D Wernicke; Stephan Felix; Gert Baumann
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

7.  Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error.

Authors:  A J Hauck; D L Kearney; W D Edwards
Journal:  Mayo Clin Proc       Date:  1989-10       Impact factor: 7.616

8.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

9.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

10.  Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.

Authors:  J G Shanes; J Ghali; M E Billingham; V J Ferrans; J J Fenoglio; W D Edwards; C C Tsai; J E Saffitz; J Isner; S Furner
Journal:  Circulation       Date:  1987-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.